SLU Researchers Enroll Participants in 2-in-1 COVID and Flu Vaccine Clinical Trial
ST. LOUIS – Saint Louis University’s Center for Vaccine Development is participating in a clinical study for an investigational vaccine being developed against influenza and COVID developed by Pfizer, which is funding this research.
While there are licensed vaccines and treatments for both influenza and COVID, the current vaccines have been given as separate shots. This study looks at whether both vaccines can be combined into one shot without affecting the antibody response to either vaccine.
Sarah George, M.D., professor of infectious diseases at SLU School of Medicine and a researcher in SLU’s Vaccine Center. SLU file photo.
Sarah George, M.D., professor of infectious diseases at SLU School of Medicine and a researcher in SLU’s Vaccine Center, will assist in studying whether the combined vaccine induces the body to make antibodies to both influenza and COVID, compared with giving both vaccines separately.
“Since it looks like COVID will be with us for the long haul, just as flu is, it’s important to see if we can combine both vaccines into one shot without compromising immunity of both,” George said. “It’s vital that we continue to work to develop combined vaccines that can protect all of us, especially the vulnerable, from these illnesses.”
The phase 3 clinical trial is being conducted at over 200 sites in the United States, including Saint Louis University. SLU researchers are recruiting around 150 healthy adults 18 through 64 years of age who have not had a flu or COVID vaccine in the past 6 months. Overall, the study will recruit 9,000 volunteers and will last about a year. Each volunteer will have 3 study visits.
To learn more about vaccine research being conducted at Saint Louis University, call 314-977-6333 or email vaccine@slu.edu. For more information on this study, please visit the ClinicalTrials.gov website link here.
Latest Newslink
- SLU Student Named Truman Scholarship FinalistSaint Louis University's Sam Aitchison has been named a finalist for the prestigious Harry S. Truman Scholarship. Aitchison is a junior majoring in finance, leadership and human resource management, and Catholic Studies. He hopes to pursue an MA in Educational Transformation and would like to eventually work for the U.S. Department of Education.
- SLU School of Medicine Receives Transformational $10 Million GiftThe gift is one of the largest and most impactful contributions in the School’s history. The donation comes from a patient who wishes to remain anonymous in honor of Gerald A. Maguire, M.D. (SOM ’91). The accomplished California-based psychiatrist has also personally pledged $100,000 to support his alma mater.
- SLU to Host 4th Annual Be Heard: Women in Leadership ConferenceSaint Louis University's Emerson Leadership Institute will host its fourth annual Be Heard: Women in Leadership conference on Friday, March 28. The free half-day event, "Fostering Dignity and Belonging," will explore the role of dignity in organizational culture.
- Fontbonne University’s Center for Bosnian Studies Moving to SLUSLU will become the permanent home of the Center’s unique oral histories, rare collections, circulating materials and growing digital archives. The move ensures that the Center’s mission continues and its work remains accessible as Fontbonne ends instruction and closes its operations after the summer term.
- Saint Louis University Offers Scholarship Opportunity to Girl Scouts of Eastern Missouri’s ADVANCE HER Leadership Movement ProgramSLU and the Girl Scouts of Eastern Missouri announced a partnership to provide a new scholarship opportunity for Girl Scouts of Eastern Missouri who wish to pursue higher education as part of the Advance HER Leadership program.
- Raymond Benoit, Ph.D.: 1936-2025Raymond P. Benoit, Ph.D., professor emeritus in English, died Friday, Jan. 24, 2025. He was 88.